Cargando…
Hepatoprotective effects of silymarin in management of liver injury caused by tuberculosis treatment
Tuberculosis (TB) is a chronic infection of global-health concern because of its high incidence, costly medical treatment, drug resistance and risk of co-infections. Anti-TB treatment involves a combination of drugs with high degree of liver toxicity, leading to drug-induced liver injury in 2–28% of...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioExcel Publishing Ltd
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259498/ https://www.ncbi.nlm.nih.gov/pubmed/37313040 http://dx.doi.org/10.7573/dic.2023-2-11 |